cancer biology

April 26, 2012

New drug mutes more melanomas

An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.

By VUMC News and Communications

April 6, 2012

Factor sensitizes cancer to radiation

Measuring levels of an enzyme in head and neck tumors may indicate how the tumor will respond to radiation therapy.

By VUMC News and Communications

March 23, 2012

Smoking stokes cells’ cancer capacity

Cellular pathways altered by chronic exposure to cigarette smoke may reveal new biomarkers to assess smoking-induced lung cancer risk.

By VUMC News and Communications

March 16, 2012

Colon cancer’s cellular crossroads

New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.

By VUMC News and Communications

January 26, 2012

Investigators seek clues to resistance to melanoma drug

Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug.

By VUMC News and Communications

January 25, 2012

Protein repairs esophageal DNA damage

A protein involved in repairing DNA damage associated with gastric reflux may play a tumor suppressor role in the esophagus and could represent a target for therapies to combat esophageal cancer.